Safety And Efficacy Of UK-432,097 In Chronic Obstructive Pulmonary Disease.

Status:
Terminated

Trial end date:
2008-07-01

Target enrollment:

Participant gender:

Safety and efficacy (measured by spirometry) of UK-432,097 administration will be tested in patients with chronic obstructive pulmonary disease.

Phase 2

Pfizer

Adenosine